Novartis To Buy Breast Cancer Therapy For Up To $3B
Novartis AG said Friday that it will acquire a breast cancer drug from U.S. developer Synnovation Therapeutics in a deal worth up to $3 billion as it seeks to strengthen its...To view the full article, register now.
Already a subscriber? Click here to view full article